Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-021373
Filing Date
2025-06-26
Accepted
2025-06-26 17:50:00
Documents
1
Period of Report
2025-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4154
  Complete submission text file 0001437749-25-021373.txt   5710
Mailing Address C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address
Boyce Sarah (Reporting) CIK: 0001629383 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42001 | Film No.: 251081563

Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Issuer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)